Aethlon Medical (AEMD) Non Operating Interest Expenses (2010 - 2021)

Aethlon Medical (AEMD) has reported Non Operating Interest Expenses for 12 consecutive years, with $125.0 the latest figure, recorded in Q2 2021.

• For the quarter ending Q2 2021, Non Operating Interest Expenses fell 82.83% year-over-year to $125.0; the trailing twelve-month figure through Jun 2021 stood at $977.0 (up 11.66% YoY), and the FY2026 full-year result was $14372.0, down 99.69% from the prior year.
• Non Operating Interest Expenses advanced to $125.0 in Q2 2021 per AEMD's latest filing, from $50.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.1 million in Q1 2017 and bottomed at $21.0 in Q3 2019.
• Historically, Non Operating Interest Expenses has averaged $139887.9 across 5 years, with a median of $55105.0 in 2018.
• The sharpest annual moves came in 2017 and 2019: Non Operating Interest Expenses soared 539.42% in 2017, then plunged 99.96% in 2019.
• Over 5 years, Non Operating Interest Expenses stood at $55912.0 in 2017, then declined by 1.44% to $55107.0 in 2018, then tumbled by 99.77% to $126.0 in 2019, then soared by 536.51% to $802.0 in 2020, then slumped by 84.41% to $125.0 in 2021.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $125.0, $50.0, and $802.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.